mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.05 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.08 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |